Vitamin c boost: could High-Dose ascorbate improve lung cancer treatment?
NCT ID NCT02905591
First seen Jan 09, 2026 · Last updated May 01, 2026 · Updated 15 times
Summary
This phase 2 trial tests whether adding high-dose vitamin C (ascorbate) to standard chemotherapy and radiation helps control non-small cell lung cancer. 43 participants received the combination therapy. The study measures tumor response and how long it takes for the cancer to progress.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Holden Comprehensive Cancer Cener
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.